225 related articles for article (PubMed ID: 22401634)
1. Cellular immunotherapy for soft tissue sarcomas.
Finkelstein SE; Fishman M; Conley AP; Gabrilovich D; Antonia S; Chiappori A
Immunotherapy; 2012 Mar; 4(3):283-90. PubMed ID: 22401634
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell immunotherapy in soft tissue sarcoma.
Indelicato DJ; Finkelstein SE
Immunotherapy; 2012 Oct; 4(10):1023-9. PubMed ID: 23148754
[TBL] [Abstract][Full Text] [Related]
3. Potential for immunotherapy in soft tissue sarcoma.
Tseng WW; Somaiah N; Engleman EG
Hum Vaccin Immunother; 2014; 10(11):3117-24. PubMed ID: 25625925
[TBL] [Abstract][Full Text] [Related]
4. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
Ackermann B; Tröger A; Glouchkova L; Körholz D; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for Soft Tissue Sarcoma: Tomorrow Is Only a Day Away.
Lee A; Huang P; DeMatteo RP; Pollack SM
Am Soc Clin Oncol Educ Book; 2016; 35():281-90. PubMed ID: 27249707
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of dendritic cell vaccines in sarcoma of the extremities.
Yu Z; Ren P; Zhang X; Zhang T; Ma B
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1065-71. PubMed ID: 19671026
[TBL] [Abstract][Full Text] [Related]
7. Immunity against soft-tissue sarcomas.
Maki RG
Curr Oncol Rep; 2003 Jul; 5(4):282-7. PubMed ID: 12781069
[TBL] [Abstract][Full Text] [Related]
8. Novel immunotherapeutic approaches to glioma.
Yamanaka R
Curr Opin Mol Ther; 2006 Feb; 8(1):46-51. PubMed ID: 16506525
[TBL] [Abstract][Full Text] [Related]
9. Soft tissue sarcoma as a model disease to examine cancer immunotherapy.
Maki RG
Curr Opin Oncol; 2001 Jul; 13(4):270-4. PubMed ID: 11429485
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
Nathenson MJ; Conley AP; Sausville E
Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
[TBL] [Abstract][Full Text] [Related]
11. Development of dendritic-cell based prostate cancer vaccine.
Tjoa BA; Murphy GP
Immunol Lett; 2000 Sep; 74(1):87-93. PubMed ID: 10996633
[TBL] [Abstract][Full Text] [Related]
12. [Vaccines for the treatment of non-small cell lung cancer].
Leduc C; Quoix E
Rev Mal Respir; 2019 Mar; 36(3):415-425. PubMed ID: 30902445
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Amedei A; Niccolai E; Prisco D
Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
[TBL] [Abstract][Full Text] [Related]
14. Current approaches in dendritic cell generation and future implications for cancer immunotherapy.
Tuyaerts S; Aerts JL; Corthals J; Neyns B; Heirman C; Breckpot K; Thielemans K; Bonehill A
Cancer Immunol Immunother; 2007 Oct; 56(10):1513-37. PubMed ID: 17503040
[TBL] [Abstract][Full Text] [Related]
15. Peptide-based immunotherapeutic approaches to glioma: a review.
Yamanaka R; Itoh K
Expert Opin Biol Ther; 2007 May; 7(5):645-9. PubMed ID: 17477802
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic approaches to sarcoma.
Linehan DC; Bowne WB; Lewis JJ
Semin Surg Oncol; 1999; 17(1):72-7. PubMed ID: 10402640
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of metastasis.
Dallal RM; Lotze MT
Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
[TBL] [Abstract][Full Text] [Related]
18. Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer.
Kajihara M; Takakura K; Kanai T; Ito Z; Matsumoto Y; Shimodaira S; Okamoto M; Ohkusa T; Koido S
World J Gastroenterol; 2016 May; 22(18):4446-58. PubMed ID: 27182156
[TBL] [Abstract][Full Text] [Related]
19. DC-based cancer vaccines.
Gilboa E
J Clin Invest; 2007 May; 117(5):1195-203. PubMed ID: 17476349
[TBL] [Abstract][Full Text] [Related]
20. From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past.
Shadbad MA; Hajiasgharzadeh K; Derakhshani A; Silvestris N; Baghbanzadeh A; Racanelli V; Baradaran B
Front Immunol; 2021; 12():623639. PubMed ID: 33692796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]